Description

4-Oxo-1,2,3,3A,4,5-Hexahydro-Pyrrolo[1,2-A]Quinoxaline-7-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new drug candidates.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of complex drug molecules, particularly those targeting the central nervous system.
• Organic Synthesis Building Block: Used in research and development for constructing novel heterocyclic compounds with potential biological activity.
• Medicinal Chemistry Research: Serves as a core scaffold for structure-activity relationship (SAR) studies in drug discovery programs.
• Active Pharmaceutical Ingredient (API) Development: Integral to the synthetic pathway of investigational new drugs in preclinical and clinical stages.
• Contract Research & Manufacturing (CRAM): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.

Basic Information

Product Name	4-Oxo-1,2,3,3A,4,5-Hexahydro-Pyrrolo[1,2-A]Quinoxaline-7-Carboxylic Acid
CAS No.	1008665-68-6
Molecular Formula	C12H12N2O3
Molecular Weight	232.24 g/mol
Synonyms	4-Oxo-1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinoxaline-7-carboxylic acid; Pyrrolo[1,2-a]quinoxaline-7-carboxylic acid, 1,2,3,3a,4,5-hexahydro-4-oxo-; 1,2,3,3a,4,5-Hexahydro-4-oxopyrrolo[1,2-a]quinoxaline-7-carboxylic acid; 7-Carboxy-1,2,3,3a,4,5-hexahydro-4-oxopyrrolo[1,2-a]quinoxaline
EINECS	Contact for details

Quality Control

Our production of 4-Oxo-1,2,3,3A,4,5-Hexahydro-Pyrrolo[1,2-A]Quinoxaline-7-Carboxylic Acid adheres to stringent quality management protocols. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the exacting standards required for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting all critical quality attributes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.